Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents

References

• Frankish H. 15 million new cancer cases per year by 2020, says WHO. Lancet 2003;361:1278
   PubMed Web of Science ®Google Scholar
• Belpomme D, Irigaray P, Sasco AJ, et al. The growing incidence of cancer: role of lifestyle and screening detection (Review). Int J Oncol 2007;30:1037–49
   PubMed Web of Science ®Google Scholar
• Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132:1133–45
   PubMed Web of Science ®Google Scholar
• Bano S, Javed K, Ahmad S, et al. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem 2011;46:5763–8
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Shaaban MA, Refaat HM, et al. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety. Eur J Med Chem 2012;53:403–7
   PubMed Web of Science ®Google Scholar
• Lal J, Gupta SK, Thavaselvam D, Agarwal DD. Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides. Eur J Med Chem 2013;64:579–88
   PubMed Web of Science ®Google Scholar
• Wang ZC, Qin YJ, Wang PF, et al. Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis. Eur J Med Chem 2013;66:1–11
   PubMed Web of Science ®Google Scholar
• Wang XM, Xu J, Li YP, et al. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo. Eur J Med Chem 2013;67:243–53
   PubMed Web of Science ®Google Scholar
• Xu F, Xu H, Wang X, et al. Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl)-sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: synthesis and biological evaluation. Part III. Bioorg Med Chem 2014;22:1487–95
   PubMed Web of Science ®Google Scholar
• Gamal El-Din MM, El-Gamal MI, Abdel-Maksoud MS, Oh CH. Synthesis, in vitro antiproliferative activity, and in silico studies of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety. Eur J Med Chem 2015;90:45–52
   PubMed Web of Science ®Google Scholar
• Choi WK, El-Gamal MI, Choi HS, et al. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies. Eur J Med Chem 2011;46:5754–62
   PubMed Web of Science ®Google Scholar
• Choi WK, El-Gamal MI, Choi HS, et al. Design, synthesis, and preliminary cytotoxicity evaluation of new diarylureas and diarylamides possessing 1,3,4-triarylpyrazole scaffold Bull. Korean Chem Soc 2012;33:98–2991
   Web of Science ®Google Scholar
• El-Gamal MI, Park YS, Chi DY, et al. New triarylpyrazoles as broad-spectrum anticancer agents: design, synthesis, and biological evaluation. Eur J Med Chem 2013;65:315–22
   PubMed Web of Science ®Google Scholar
• El-Gamal MI, Choi HS, Cho HG, et al. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line. Arch Pharm (Weinheim) 2011;344:745–54
   PubMed Web of Science ®Google Scholar
• El-Gamal MI, Choi HS, Yoo KH, et al. Antiproliferative diarylpyrazole derivatives as dual inhibitors of the ERK pathway and COX-2. Chem Biol Drug Des 2013;82:336–47
   PubMed Web of Science ®Google Scholar
• Dietrich JD. The design, synthesis, and evaluation of novel DFG-out allosteric kinase inhibitors. Available from: http://gradworks.proquest.com/33/38/3338842.html [last accessed 22 Apr 2016]
   Google Scholar
• Honndorf VS, Coudevylle N, Laufer S, et al. Angew Chem Int Ed 2008;47:3548–51
   PubMed Web of Science ®Google Scholar
• Gavilan MD, Gomez-Vidal JA, Serrano FR. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: preliminary cDNA microarray studies. Bioorg Med Chem Lett 2008;18:1457–60
   PubMed Web of Science ®Google Scholar
• Abdel-Maksoud MS, Kim MR, El-Gamal MI, et al. Design, synthesis, in vitro antiproliferative evaluation, and kinase 10 inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives. Eur J Med Chem 2015;95:453–63
   PubMed Web of Science ®Google Scholar
• Abdel-Mohsen HT, Ragab FAF, Ramla MM, Diwani HIE. Novel benzimidazole-pyrimidine conjugates as potent antitumor agents. Eur J Med Chem 2010;45:2336–44
   PubMed Web of Science ®Google Scholar
• Claudi F, Giorgioni GD, Stefano A, et al. Synthesis and pharmacological characterization of 2-(4-chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl derivatives as dopamine receptor ligands. J Med Chem 1992;35:4408–14
   PubMed Web of Science ®Google Scholar
• Weinstock J, Gaitanopoulos D, Oh HJ, et al. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins. J Med Chem 1986;29:1615–27
   PubMed Web of Science ®Google Scholar
• Lee J, Kim H, Yu H, et al. Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines. Bioorg Med Chem Lett 2010;20:1573–7
   PubMed Web of Science ®Google Scholar
• Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949–54
   PubMed Web of Science ®Google Scholar
• Wickenden JA, Jin H, Johnson M, et al. Colorectal cancer cells with the BRAFV600E mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM. Oncogene 2008;27:7150–61
   PubMed Web of Science ®Google Scholar
• Subramanian RR, Yamakawa A. Combination therapy targeting Raf-1 and MEK causes apoptosis of HCT116 colon cancer cells. Int J Oncol 2012;41:1855–62
   PubMed Web of Science ®Google Scholar
• Thiel A, Ristimaki A. Toward a molecular classification of colorectal cancer: the role of BRAF. Front Oncol 2013;3:281
   PubMedGoogle Scholar